(Q30984906)

28 June 2017

Mutations in the pfmdr1, dhfr and dhps genes of Plasmodium falciparum are associated with in-vivo drug resistance in West Papua, Indonesia (English)

1 reference

28 June 2017

0 references

0 references

Plasmodium falciparum

0 references

0 references

Reeder JC

6

0 references

author name string

Nagesha HS

1

1 reference

28 June 2017

Din-Syafruddin

2

1 reference

28 June 2017

Casey GJ

3

1 reference

28 June 2017

Susanti AI

4

1 reference

28 June 2017

Fryauff DJ

5

1 reference

28 June 2017

Cowman AF

7

1 reference

28 June 2017

language of work or name

1 reference

1 January 2001

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

28 June 2017

1 reference

28 June 2017

95

1 reference

28 June 2017

43-49

1 reference

28 June 2017

1

1 reference

Genetic evidence that RI chloroquine resistance of Plasmodium falciparum is caused by recrudescence of resistant parasites

28 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

pfmdr1 gene mutation and clinical response to chloroquine in Yaoundé, Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

Assessment of the association between three pfmdr1 point mutations and chloroquine resistance in vitro of Malaysian Plasmodium falciparum isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanil-dapsone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

Prolonged incubation improves the micro-scale in-vitro test for drug sensitivity of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

Pyrimethamine-sulfadoxine still effective against Plasmodium falciparum in Jayapura, Irian Jaya: RI-type resistance in 2 of 18 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian schoolchildren.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

Whole blood concentrations of chloroquine and desethylchloroquine during and after treatment of adult patients infected with Plasmodium vivax, P. ovale or P. malariae

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

More on 'the efficacy of antifolate antimalarial combinations in Africa'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

Kinetic and molecular properties of dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium chabaudi

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

7 January 2021

Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: evidence for quinine resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

7 January 2021

Resistance to Chloroquine by Plasmodium vivax in Irian Jaya, Indonesia

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

7 January 2021

Chloroquine resistance ofPlasmodium falciparumin West Irian and East Kalimantan

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

7 January 2021

In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990329-3

7 January 2021

10.1016/S0035-9203(01)90329-3

Identifiers

DOI

1 reference

28 June 2017

1 reference